IPAC2021 - List of Authors (Mandrillon, J.)

Paper	Title	Page
TUPAB188	InnovaTron: An Innovative High-Intensity Industrial Cyclotron for Production of Tc-99m and Other Frontier Medical Radioisotopes*	1841
	G. D’Agostino, Q. Flandroy, E. Forton, W.J.G.M. Kleeven, J. Mandrillon, V. Nuttens, E. van der Kraaij IBA, Louvain-la-Neuve, Belgium
	Funding: This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 886190. Tc-99m is the most used radioisotope in nuclear medicine. It is almost exclusively produced with a few ageing research reactors worldwide. In response to growing concerns about Tc-99m availability and its increasing demand, alternative production routes are being explored. The EU-funded InnovaTron project aims at designing an innovative compact high-intensity self-extracting cyclotron able to deliver proton beams with currents up to 5 mA or more for the direct production of Tc-99m. It could be also used for production of high quantities of other frontier medical radioisotopes. The proton beams exit without using an electrostatic deflector to overcome its current limitations. A prototype cyclotron was built by IBA in 2001. Currents up to 2 mA were extracted from it. However, at higher intensities, the extraction efficiency was not higher than 70-75% and the extracted emittance was rather large. The InnovaTron project will implement new technological solutions in the self-extracting cyclotron to be used for large-scale industrial applications. An overview on the InnovaTron project is here presented together with the first simulation results.
DOI •	reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2021-TUPAB188
About •	paper received ※ 18 May 2021 paper accepted ※ 01 June 2021 issue date ※ 25 August 2021
Export •	reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

Paper

Title

Page

InnovaTron: An Innovative High-Intensity Industrial Cyclotron for Production of Tc-99m and Other Frontier Medical Radioisotopes*

1841

G. D’Agostino, Q. Flandroy, E. Forton, W.J.G.M. Kleeven, J. Mandrillon, V. Nuttens, E. van der Kraaij
IBA, Louvain-la-Neuve, Belgium

Funding: This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 886190.
Tc-99m is the most used radioisotope in nuclear medicine. It is almost exclusively produced with a few ageing research reactors worldwide. In response to growing concerns about Tc-99m availability and its increasing demand, alternative production routes are being explored. The EU-funded InnovaTron project aims at designing an innovative compact high-intensity self-extracting cyclotron able to deliver proton beams with currents up to 5 mA or more for the direct production of Tc-99m. It could be also used for production of high quantities of other frontier medical radioisotopes. The proton beams exit without using an electrostatic deflector to overcome its current limitations. A prototype cyclotron was built by IBA in 2001. Currents up to 2 mA were extracted from it. However, at higher intensities, the extraction efficiency was not higher than 70-75% and the extracted emittance was rather large. The InnovaTron project will implement new technological solutions in the self-extracting cyclotron to be used for large-scale industrial applications. An overview on the InnovaTron project is here presented together with the first simulation results.

DOI •

reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2021-TUPAB188

About •

paper received ※ 18 May 2021 paper accepted ※ 01 June 2021 issue date ※ 25 August 2021

Export •

reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)